Dan,s outlook is bright17 Nov 2025 12:24
Excerpt from RNS,
Dr Dan Gooding, Executive Director, Nuformix, said: "We will respond to FDA using the data we already have on file, having previously had a similar query from the EMA. I remain confident the process will reach a successful conclusion and whilst we await the FDA's further response we continue to progress discussions with potential future licensing partners and will provide further updates in due course as appropriate."
Another two weeks, Dan will have his approval ,Bingo, cogs in the machinery will start turning.
Roll on next year , big business in the USA alone.
What's not to like , Good luck to the team.